24 March 2022 - Ponesimod is a sphingosine 1 phosphate receptor 1 modulator.

Ponvory is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS) with active disease defined by clinical or imaging features.

Read Australian prescription medicine decision summary for ponesimod